Clinical trial
Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients…
NCT00187551 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00187551 |
|---|---|
| Title | Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance |
| Official title | Partial Treatment Interruptions in HIV-1 Patients With Multi-Drug Resistant Virus |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | Universitywide AIDS Research Program |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Other |
| Interventions | Interruption of enfuvirtide, enfuvirtide interrupton |
| Enrollment | 25 |
| Start date | May 1, 2000 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 10, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: